28 related articles for article (PubMed ID: 23218062)
1. Auditory musical hallucinations associated with extended-release pramipexole in an elderly patient with Parkinson's disease.
Kataoka H; Ueno S
Medicine (Baltimore); 2014 Dec; 93(27):e251. PubMed ID: 25501095
[TBL] [Abstract][Full Text] [Related]
2. Long-term retention rate of pramipexole in the treatment of Parkinson's disease.
Keränen T; Tuhkasaari M; Kuusisto H
Eur J Clin Pharmacol; 2009 Sep; 65(9):955-6; author reply 957. PubMed ID: 19415250
[No Abstract] [Full Text] [Related]
3. A case of severe leg oedema in a patient with Parkinson's disease treated with pramipexole.
Cicero CE; Nicoletti A; Mostile G; Zappia M
Postgrad Med J; 2016 Aug; 92(1090):484. PubMed ID: 26941267
[No Abstract] [Full Text] [Related]
4. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease.
Katz KA; Cotsarelis G; Gupta R; Seykora JT
J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S103-4. PubMed ID: 17052518
[No Abstract] [Full Text] [Related]
5. Exercise dependence induced by pramipexole in Parkinson's Disease-a case report.
Vitale C; Santangelo G; Verde F; Amboni M; Sorrentino G; Grossi D; Barone P
Mov Disord; 2010 Dec; 25(16):2893-4. PubMed ID: 20687190
[No Abstract] [Full Text] [Related]
6. Pramipexole-induced obsessive-compulsive symptoms in a patient with Parkinson's disease and disgust sensitivity.
Gopalan P; Azzam PN; Hudak R
Psychosomatics; 2013; 54(3):286-9. PubMed ID: 23218062
[No Abstract] [Full Text] [Related]
7. Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease.
Perez Lloret S; Rascol O
Expert Opin Pharmacother; 2010 Sep; 11(13):2221-30. PubMed ID: 20670197
[TBL] [Abstract][Full Text] [Related]
8. Pramipexole extended release in Parkinson's disease.
Hametner EM; Seppi K; Poewe W
Expert Rev Neurother; 2011 Sep; 11(9):1229-34. PubMed ID: 21864066
[TBL] [Abstract][Full Text] [Related]
9. Pramipexole extended release: in Parkinson's disease.
Chwieduk CM; Curran MP
CNS Drugs; 2010 Apr; 24(4):327-36. PubMed ID: 20297857
[TBL] [Abstract][Full Text] [Related]
10. [Parkinson's disease and obsessive-compulsive spectrum].
López-Moríñigo JD; Ramos-Ríos R; Martínez-Formoso S; Arrojo-Romero M; Ecénarro-Tomé P
Rev Neurol; 2009 Aug 16-31; 49(4):202-9. PubMed ID: 19621323
[TBL] [Abstract][Full Text] [Related]
11. Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.
Ahlskog JE
Physiol Behav; 2011 Jul; 104(1):168-72. PubMed ID: 21557955
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
